TNGX profile · all as-reported value updates
Tango Therapeutics, Inc. (TNGX) as-reported value updates
Descriptive filing record — not investment advice. This page compares two SEC XBRL-filed values for the same fiscal period. It does not state why the values differ and is not a rating, score, or recommendation. See Disclaimer.
Reported values for the same fiscal period can differ between filings for many routine reasons: re-presentation for discontinued operations, adoption of new accounting standards, reclassifications, changes in rounding precision, and amendments. This ledger records that the filed values differ; it does not and cannot determine why. Both filings are linked below so the reader can consult the source.
Ledger table figure
| Metric | FY | Earliest XBRL-filed value | Currently on file | Difference | Difference % | Label | Filing links | Notes |
|---|---|---|---|---|---|---|---|---|
| Liabilities | 2020 | 5,950,604 | 168,652,000 | 162,701,396 | +96.47% | revised comparative figure | 0001213900-21-019249 0000950170-22-004721 | 2 filed observations examined for this concept and period. |
| Cash and cash equivalents | 2020 | 1,314,085 | 28,381,000 | 27,066,915 | +95.37% | revised comparative figure | 0001213900-21-019249 0000950170-22-004721 | 2 filed observations examined for this concept and period. |
| Stockholders' equity | 2020 | 5,000,002 | 38,600,000 | 33,599,998 | +87.05% | revised comparative figure | 0001213900-21-019249 0000950170-23-009854 | 3 filed observations examined for this concept and period. |
| Assets | 2020 | 168,312,816 | 207,252,000 | 38,939,184 | +18.79% | revised comparative figure | 0001213900-21-019249 0000950170-22-004721 | 2 filed observations examined for this concept and period. |